<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The INK4A locus encodes two <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes, p16(INK4A) and p14(ARF), transcribed using alternative exons 1alpha or 1beta spliced onto the same exons 2 and 3 </plain></SENT>
<SENT sid="1" pm="."><plain>Both p16(INK4A) and p14(ARF) are capable of inhibiting the cell-cycle progression, albeit in different manner; p16(INK4A) is phosphorylation of <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> (pRB) dependent while p14(ARF) is p53-dependent </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we report the discovery of a novel variant of p16(INK4A), termed p16gamma, in a primary T-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>) patient sample and a <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> cell line, which was expressed at both the transcriptional and translational levels </plain></SENT>
<SENT sid="3" pm="."><plain>Cloning and sequencing of the p16gamma cDNA revealed that p16gamma was identical to p16(INK4A), except that it contained an in-frame insertion of 197 bp between exons 2 and 3 </plain></SENT>
<SENT sid="4" pm="."><plain>p16gamma expression was detected in the majority of p16(INK4A)-expressing primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> and <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> patient samples and other p16(INK4A)-expressing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples, but was only barely detectable in some <z:mpath ids='MPATH_458'>normal</z:mpath> mononuclear cells and other non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples </plain></SENT>
<SENT sid="5" pm="."><plain>Structural analysis by nuclear magnetic resonance and circular dichroism confirmed that p16gamma, like p16(INK4A), is also an ankyrin-repeat protein </plain></SENT>
<SENT sid="6" pm="."><plain>Functional analysis of p16gamma revealed that p16gamma protein interacted with cyclin D-dependent kinase4 and inhibited its kinase activity </plain></SENT>
<SENT sid="7" pm="."><plain>Using a luciferase reporter assay, the transfection of p16gamma repressed the E2F response, the downstream target of pRB, with an efficacy equivalent to that of p16(INK4A) </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover p16gamma, like p16(INK4A), induced cell-cycle arrest at G(0)/G(1), and inhibited cell growth in colony formation assay </plain></SENT>
</text></document>